99mTc-MIRC208 SPECT/CT Imaging for HER2-Positive Cancer Patients

Condition:   Cancer Intervention:   Drug: 99mTc-MIRC208 Sponsor:   Beijing Cancer Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials